THE FEDERAL-REGULATION OF PRESCRIPTION DRUG ADVERTISING AND PROMOTION

被引：77

作者：

KESSLER, DA ^{[1
]}

PINES, WL ^{[1
]}

机构：

[1] BURSON MARSTELLER,WASHINGTON,DC

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1990年 / 264卷 / 18期

关键词：

D O I：

10.1001/jama.264.18.2409

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2409 / 2415

页数：7

共 65 条

[1] ADAMS DG, 1989, FEB DRUG INF ASS DIA
[2] BUCCERI DJ, 1985, COMMUNICATION 0903
[3] BYERS TE, 1978, COMMUNICATION 1121
[4] CAVANAUGH TW, 1985, COMMUNICATION 1009
[5] CAVANAUGH TW, 1985, COMMUNICATION 0819
[6] CAVERS, 1939, LAW CONTEMP PROB, V6, P2
[7] DIRECT-TO-THE-PUBLIC ADVERTISEMENT OF PRESCRIPTION DRUGS
COHEN, EP
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (06) : 373 - 376
[8] COOPER RM, 1989, LEGAL BASIS FDAS REG
[9] DREYFUS J, 1981, REMARKABLE MED HAS B
[10] EDELSON RC, 1980, NJ LAWYER MAY, P33